La EMA sobre los problemas sanguíneos detectados en la vacuna AstraZeneca

 

 --

 Declaración de la Agencia Europea de Medicamentos EMA sobre los problemas sanguíneos detectados en la vacuna AstraZeneca

-

•  A review by the EU's medicines regulator has concluded the Oxford-AstraZeneca Covid-19 vaccine is "safe and effective".

The European Medicines Agency (EMA) investigated after 13 EU states suspended use of the vaccine over fears of a link to blood clots.

It found the jab was "not associated" with a higher risk of clots.

Italy and Spain announced it would resume using the jab, while Sweden said it needed a "few days" to decide.

It is up to individual EU states to decide whether and when to re-start vaccinations using the AstraZeneca vaccine...

-

 "La vacuna de AstraZeneca​ es segura, eficaz y los beneficios superan los riesgos" según la Agencia Europea de Medicamentos EMA que no ve enlaces con los problemas de coágulos sanguíneos.

--